Introduction
============

Ovarian torsion has been described as rotation of the adnexa around its vascular axis. It is a rarely encountered surgical emergency and requires prompt diagnosis and treatment. Clinical presentation is non-specific and there are often significant delays between the onset of symptoms and operative intervention.[@b1-dddt-12-409] For all age groups, traditional management was resection of the ischemic-appearing ovary because of the theoretical risk of thromboembolism, the concern of associated malignancy and the belief that a grossly blue--black and hemorrhagic adnexa was non-viable. Long-term analysis of the cases treated by detorsion revealed that the method is safe and can save the ovary. So, management has changed and today laparoscopic detorsion as soon as possible is the preferred method in premenopausal women.[@b2-dddt-12-409]

Reperfusion by detorsion protects the ovary from ischemic damage. However, during the reperfusion period tissue damage continues because of oxygen-derived free radicals. Due to its results, the torsion--detorsion process is named ischemia/reperfusion (I/R) injury.[@b3-dddt-12-409] Several methods have been tried to prevent this injury.[@b4-dddt-12-409],[@b5-dddt-12-409] Pharmacologic conditioning with different drugs, having antioxidant and anti-inflammatory properties, has been tested to determine their preventive effect on I/R injury.[@b6-dddt-12-409],[@b7-dddt-12-409]

Magnesium is found in large amounts both in intracellular and extracellular spaces of the body. It is important for numerous physiological events and is used as a therapeutic agent in many areas of medicine like neurology, cardiology, gastroenterology and obstetrics. Magnesium is a powerful antioxidant and a potent anti-inflammatory agent. It inhibits endotoxin-related inflammatory molecule upregulation.[@b8-dddt-12-409] Magnesium is an L-type calcium channel blocker and in this way may decreases calcium overload of the tissue which is an important factor in tissue damage.[@b9-dddt-12-409] Magnesium also provides cellular protection by stabilizing the cell membrane potential and decreasing energy need.[@b10-dddt-12-409]

Despite all these important effects, nothing is known about the effect of magnesium on I/R injury of the ovary. We aimed to explore whether MgSO~4~ could prevent I/R injury in rat ovaries.

Materials and methods
=====================

Approval of the study was provided by Firat University local ethics committee for animal research and adhered to guidelines prepared according to EU Directive 2010/63/EU. Experiments were done in a laboratory of the same university. By performing daily vaginal smears, animals showing regular cycles were selected. Forty-two female Sprague Dawley rats weighing between 200 and 250 g, aged 10--12 weeks, were taken and allocated randomly into six groups: • Group 1: sham (n=7) Group 2: bilateral ovarian torsion (n=7)Group 3: bilateral ovarian torsion--detorsion (n=7)Group 4: MgSO~4~--sham (n=7)Group 5: MgSO~4~--bilateral ovarian torsion (n=7)Group 6: bilateral ovarian torsion--MgSO~4~--detorsion (n=7)

Operations were done under anesthesia. Ketamine hydrochloride (50 mg/kg Ketalar; Eczacibasi, Istanbul, Turkey) and xylazine hydrochloride (7 mg/kg Rompun; Bayer, Istanbul, Turkey) were used intramuscularly. Under anesthesia, the animals were placed in prone position on the operating table. The surgical field was shaved, and antisepsis was performed. Two imaginary points, 1--1.5 cm lateral from the point where the last rib of the animal joined with the vertebrae, were identified on both sides of the back of the animal. New points 1--1.5 cm caudal to the first points were found and incisions measuring nearly 1 cm were made. Through passing the muscular layer, the abdominal cavity was reached. The encountered fat layer was carefully removed from the incision out of the abdomen. Next to the fat tissue, the ovary was observed. In Group 1, after 3 minutes the ovary was put back into the abdomen using the same incision and the incision was closed. This procedure was repeated for both sides. After a 3-hour period, euthanasia was performed and both ovaries were taken. In Group 2, bilateral ovarian ischemia was induced by putting a knot that can be opened easily just below the ovary, instead of applying vascular clips. A No 1 silk suture was used for this procedure ([Figure 1](#f1-dddt-12-409){ref-type="fig"}). Both ovaries were removed 3 hours after placing the knot. In Group 3, after performing ischemia for 3 hours, sutures were removed, and the ovaries were reperfused for 3 hours before removal. In Group 4, MgSO~4~ (600 mg/kg) was given intraperitoneally 30 minutes before performing a sham operation. In Group 5, 30 minutes after intraperitoneal MgSO~4~ application, ischemia was induced, and the ovaries were taken out after a 3-hour ischemia. In Group 6, an ischemia period lasting 3 hours was performed and MgSO~4~ was administered intraperitoneally 30 minutes before reperfusion. After the 3-hour reperfusion period both ovaries were taken out. In all groups, one ovary was taken for biochemical analysis and the remaining ovary for histopathological examination. Ovarian tissue samples taken for biochemical analysis were stored at −80°C.

Histological examination
------------------------

Tissues were fixed in formalin, dehydrated by alcohol, cleared in xylene and put in paraffin blocks. Fragments 5 µm thick were cut and hematoxylin and eosin staining was performed. They were analyzed and photographed by the same pathologist in a blind manner using a Leica DM 500 photomicroscope (Leica DFC 295; Leica Microsystems, Wetzlar, Germany). The criteria for ovarian injury were interstitial edema, hemorrhage and polymorphonuclear leukocyte infiltration. Each parameter was scored between 0 and 3, in which 0 indicates absence of abnormal finding and 1, 2 and 3 indicate pathologic findings in \<33%, 33%--66% and \>66% of ovary, respectively. In each group, we added up the results of each parameter and obtained a score.

Biochemical analysis
--------------------

The ovarian tissues were homogenized with phosphate buffer (50 mmol/L, pH 7.0) for 3 minutes on ice. They were centrifuged at 10,000 rpm for 10 minutes at 4°C to determine malondialdehyde (MDA) and glutathione (GSH) levels and catalase (CAT), glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities. The modified method of Ohkawa et al was used to determine MDA concentrations and results were expressed as nmol/g protein.[@b11-dddt-12-409] Tissue GSH levels were measured by the dithio-nitrobenzoic acid recycling method described by Ellman and the results were given as nmol/mg protein.[@b12-dddt-12-409] CAT activities were determined according to the method of Aebi and results were given as k/g protein, where k is the first-order rate constant.[@b13-dddt-12-409] GSH-Px activities were determined by the method of Paglia and Valentine.[@b14-dddt-12-409] The oxidation of NADPH was followed spectrophotometrically at 340 nm and results were given as U/g protein. SOD activities were measured by the method of Sun et al and a slightly modified method by Durak et al.[@b15-dddt-12-409],[@b16-dddt-12-409] Tissue SOD activities were given as U/g protein. Protein concentrations were determined according to the method of Lowry et al.[@b17-dddt-12-409] Total oxidant status (TOS) and total antioxidant status (TAS) were determined using commercial kits (Rel Assay Diagnostics, Gaziantep, Turkey) on an Advia 2400 analyzer (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA).[@b18-dddt-12-409],[@b19-dddt-12-409] The TOS measurement method was based on the oxidation of ferrous ion-o-dianisidine complex to ferric ion by the oxidants present in the sample. The assay method was calibrated with hydrogen peroxide and results were expressed as µmol H~2~O~2~ Eq/g protein. The TAS measurement method was based on the reduction of dark blue--green colored 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) radical to the colorless reduced 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) form with the antioxidants present in the sample. The assay was calibrated with Trolox and results were given as mmol Trolox Eq/g protein. The Oxidative Stress Index (OSI) was defined as the percent ratio of TOS to TAS levels.

Statistical analysis
--------------------

Results are given as the mean ± SD. One-way analysis of variance and post hoc Tukey tests were used for statistical analyses. For statistical analyses, SPSS version 22.0 (IBM Corporation, Armonk, NY, USA) was utilized. *p*\<0.05 was considered statistically significant.

Results
=======

All the torsioned and detorsioned ovaries showed blue--black discoloration macroscopically. Histopathologic evaluation scores are given in [Table 1](#t1-dddt-12-409){ref-type="table"}.

This evaluation revealed that ovaries were normal in the sham and MgSO~4~--sham groups ([Figure 2A and D](#f2-dddt-12-409){ref-type="fig"}, respectively). Compared to the sham group, increase in edema (black star) and hemorrhage (black arrow) was not statistically significant in the torsion group ([Figure 2B](#f2-dddt-12-409){ref-type="fig"}) (*p*\>0.05). Increase in these parameters was significant in the torsion--detorsion group compared to the sham group ([Figure 2C](#f2-dddt-12-409){ref-type="fig"}) (*p*\<0.05).

Decrease in interstitial edema, hemorrhage and inflammatory cells was observed in the MgSO~4~--torsion group compared to the torsion group ([Figure 2E](#f2-dddt-12-409){ref-type="fig"}) but differences were not significant (*p*\>0.05).

A significant increase in edema, hemorrhage and inflammatory cells (green arrow) was observed in the torsion--detorsion group compared to the torsion group (*p*\<0.05).

In the torsion--MgSO~4~--detorsion group ([Figure 2F](#f2-dddt-12-409){ref-type="fig"}), we observed a statistically insignificant decrease in interstitial edema and hemorrhage and a statistically significant decrease in inflammatory cells compared to the torsion--detorsion group (*p*\>0.05 and *p*\<0.05, respectively).

Levels of TOS, TAS, OSI, MDA and GSH and activities of SOD, CAT and GSH-Px of ovarian tissues for each group are presented in [Table 2](#t2-dddt-12-409){ref-type="table"}.

Both adnexial torsion and torsion--detorsion caused significant increase in tissue MDA levels (*p*\<0.05 and *p*\<0.001, respectively). MDA levels were statistically lower in the torsion--MgSO~4~ group than in the torsion group (*p*\<0.01) and were statistically lower in the torsion--MgSO~4~--detorsion group than in the torsion--detorsion group (*p*\<0.001).

Torsion--detorsion caused a significant decrease in activity of GSH-Px (*p*\<0.05) and the level of GSH (*p*\<0.001) compared to the sham group. Administration of MgSO~4~ caused a higher tissue activity of GSH-Px and level of GSH in the torsion--MgSO~4~ group compared to the torsion group (*p*\<0.05, for both). We also demonstrated a higher GSH-Px activity and GSH level in the torsion--MgSO~4~--detorsion group than in the torsion--detorsion group (*p*\<0.05, for both).

Torsion caused an insignificant decrease but torsion--detorsion caused a statistically significant decrease in the activity of catalase (*p*\<0.05). Administration of MgSO~4~ caused a statistically insignificant increase in catalase levels in all the applied groups. Changes in the activity of SOD were not significant in any of the groups (*p*\>0.05).

We also demonstrated that TOS levels were higher in the torsion and torsion--detorsion groups when compared to the sham group (*p*\<0.05 and *p*\<0.001, respectively). TOS levels were lower in the MgSO~4~ applied torsion and detorsion groups when compared to the torsion only and torsion--detorsion only groups (*p*\<0.01 and *p*\<0.001, respectively). OSI levels were higher in the torsion--detorsion group when compared to the sham group (*p*\<0.001). MgSO~4~ administration caused significantly lower OSI levels in the MgSO~4~-treated torsion--detorsion group when compared to the torsion--detorsion only group (*p*\<0.001).

Discussion
==========

Through the advances in organ-preserving surgeries in many fields of medicine, not only ischemic injuries but also reperfusion injuries became important. Studies investigating the prevention of these damages have gained speed.[@b20-dddt-12-409],[@b21-dddt-12-409] Since management of ovarian torsion by detorsion causes a form of I/R injury, measures taken to avoid this damage also became important in the area of gynecology. Ozler et al also demonstrated that surgical detorsion is not sufficient to protect ovarian reserve in an experimental torsion--detorsion model.[@b22-dddt-12-409] Torsion causes ischemic changes, which can be demonstrated by biochemical analysis, in the ovary. Detorsion, as soon as possible, is an important step in the prevention of ovarian damage but alone it does not prevent ovarian damage. By detorsion, reperfusion is established, and reactive oxygen species are created.[@b23-dddt-12-409] In an organism, there is a balance between the production and destruction rate of free radicals and it is known as "oxidative balance". An imbalance that occurs in favor of free radicals is called "oxidative stress". These radicals cause lipid peroxidation in the cell. It is known that the primary mechanism underlying tissue damage is lipid peroxidation and inhibiting or decreasing lipid peroxidation can be a basic strategy in order to prevent tissue injury. MDA levels show oxidative stress and increase through lipid peroxidation. Literature examination revealed that MDA levels were increased in many studies related to I/R injuries.[@b20-dddt-12-409],[@b24-dddt-12-409] In our study, we determined increased levels of MDA in both the torsion and torsion--detorsion groups compared to the sham group. Significant reduction in MDA levels was observed when MgSO~4~ was given before torsion and detorsion. As a result of this, we can conclude that MgSO~4~ can decrease lipid peroxidation and so the tissue injury. Other studies also proved that magnesium deficiency enhances lipid peroxidation and supplementation reduces lipid peroxidation.[@b25-dddt-12-409],[@b26-dddt-12-409] To prevent the damage caused by reactive oxygen radicals, different biological defense systems are present in cells. CAT, SOD and GSH-Px are the best-known ones. In our study, application of MgSO~4~ caused statistically non-significant increases in tissue levels of SOD and CAT. We also found that levels of GSH-Px decreased significantly in the torsion--detorsion group and administration of MgSO~4~ caused significantly higher tissue levels of GSH-Px when compared to untreated groups. This result shows that administration of MgSO~4~ increases biological defense mechanisms against reactive oxygen radicals.

GSH is a substrate for GSH-Px and has antioxidant activity in many cells. We demonstrated that both torsion and torsion--detorsion caused a significant decrease in tissue levels of GSH. Application of MgSO~4~ increased the GSH levels significantly in all groups. Since synthesis of GSH is magnesium dependent, the antioxidant property of magnesium might be also related to the GSH pathway.

OSI is a marker for the degree of oxidative stress and is the combined ratio between TOS and TAS. In our study, torsion--detorsion caused a significant increase in the level of TOS and OSI. Administration of MgSO~4~ caused significantly lower tissue levels of TOS and OSI in the torsion--MgSO~4~--detorsion group.

Histologic examination revealed that torsion--detorsion caused a statistically significant increase in the scores of edema, hemorrhage and inflammatory cells. Administration of MgSO~4~ caused a decrease in all scores but only the decrease in inflammatory cells was significant. Inflammatory cells are important in tissue damage.

The effects of magnesium on I/R injury of different organs have been investigated. Studies demonstrated that administration of magnesium reduced renal I/R injury in rat experimental models.[@b27-dddt-12-409] Kao et al demonstrated that MgSO~4~ significantly reduced the oxidative stress and inflammatory response caused by bilateral lower limb I/R in rats.[@b8-dddt-12-409] Data from different studies support that brain damage caused by hypoxia and radiation-induced oxidative stress of the spinal cord could be diminished by MgSO~4~.[@b28-dddt-12-409],[@b29-dddt-12-409] Kim et al showed that administration of magnesium before reperfusion of liver transplantation significantly reduced blood lactate levels.[@b30-dddt-12-409] Kaptanoglu et al demonstrated that administration of magnesium reduced the I/R injury on fetal rat skin.[@b31-dddt-12-409] A free radical reducing effect of magnesium in a coronary occlusion reperfusion model was demonstrated by Garcia et al.[@b32-dddt-12-409] It was also demonstrated that magnesium reduces the lactate and MDA levels after cerebral ischemia.[@b33-dddt-12-409] It was shown that application of Lomodex--MgSO~4~ prior to detorsion increases semen quality and fertility.[@b34-dddt-12-409] There are many other beneficial effects of magnesium. It is known that magnesium can inhibit thrombus formation.[@b35-dddt-12-409] Ravn et al demonstrated that magnesium can inhibit arterial thrombus formation.[@b36-dddt-12-409] Magnesium also increases red cell deformability.[@b37-dddt-12-409] After the discovery of the importance of calcium in ischemic cell death, calcium antagonists have come into focus for protection from ischemic damage. Magnesium is a physiological calcium antagonist. It competes with calcium ions for ion channels or receptor binding. Inhibition of calcium entry into the cell by magnesium may serve an additional benefit in ovarian I/R injury.

Magnesium also causes blood vessel dilatation. It can reduce infarct size in ischemia.[@b38-dddt-12-409] We did not try to explore these effects of magnesium in our study, but these properties of magnesium may provide additional benefits in the case of torsion--detorsion induced ovarian damage.

Conclusion
==========

This is the first study to investigate the effects of magnesium on I/R induced injury of the ovary. Magnesium is an easily accessible inexpensive drug. Obstetricians and gynecologists are familiar with it and can use the drug safely. In the light of previous reports and our study, we can enounce that MgSO~4~ may save the ovary from I/R injury. A limitation of our study is the absence of long-term influences of MgSO~4~. Further studies are needed to define the best effective dose, duration, other mechanisms of action and long-term effects before its usage in clinical practice.
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![Torsion model performed in ovaries.](dddt-12-409Fig1){#f1-dddt-12-409}

![Histopathologic examination of the tissues (hematoxylin and eosin).\
**Notes:** (**A**) sham group, (**B**) torsion group, (**C**) torsion--detorsion group, (**D**) MgSO~4~--sham group, (**E**) MgSO~4~--torsion group, (**F**) torsion--MgSO~4~--detorsion group. (**A**, **D**) normal ovarian tissue structures in the sham and sham--MgSO~4~ groups, (**B**, **E**) increase in edema (black star) and hemorrhage (black arrow) in the torsion and MgSO~4~--torsion groups. (**C**) More prominent edema (black stars), hemorrhage (black arrows) and inflammatory cell infiltration (green arrows) in the torsion--detorsion group, (**F**) decrease in inflammatory cells with persistence of edema (black star) and hemorrhage (black arrows) in the MgSO~4~ applied torsion--detorsion group.\
**Abbreviation:** MgSO~4~, magnesium sulfate.](dddt-12-409Fig2){#f2-dddt-12-409}

###### 

Distribution of histopathologic evaluation scores in all groups

  Group     Edema                                                                                              Hemorrhage                                                                                         Inflammatory cell
  --------- -------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------
  Group 1   0.50±0.83                                                                                          0.33±0.51                                                                                          0.83±0.98
  Group 2   1.16±1.16                                                                                          0.83±0.75                                                                                          1.00±01.26
  Group 3   2.83±0.40[a](#tfn2-dddt-12-409){ref-type="table-fn"},[b](#tfn3-dddt-12-409){ref-type="table-fn"}   2.66±0.51[a](#tfn2-dddt-12-409){ref-type="table-fn"},[b](#tfn3-dddt-12-409){ref-type="table-fn"}   2.80±0.44[a](#tfn2-dddt-12-409){ref-type="table-fn"},[b](#tfn3-dddt-12-409){ref-type="table-fn"}
  Group 4   0.66±0.81                                                                                          0.50±0.83                                                                                          0.50±0.83
  Group 5   1.00±1.09                                                                                          0.50+0.54                                                                                          0.66±0.81
  Group 6   1.16±0.75                                                                                          2.16±0.75[a](#tfn2-dddt-12-409){ref-type="table-fn"}                                               0.83±0.40[c](#tfn4-dddt-12-409){ref-type="table-fn"}

**Notes:** Group 1, sham; Group 2, bilateral ovarian torsion; Group 3, bilateral ovarian torsion--detorsion; Group 4, MgSO~4~--sham; Group 5, MgSO~4~--bilateral ovarian torsion; Group 6, bilateral ovarian torsion--MgSO~4~--detorsion. Data are expressed as the mean ± standard deviation.

*p*\<0.05 when compared to Group 1;

*p*\<0.05 when compared to Group 2;

*p*\<0.05 when compared to Group 3. Data presented as mean ± SD.

**Abbreviation:** MgSO~4~, magnesium sulfate.

###### 

Ovarian tissue TOS, TAS, OSI, MDA and GSH levels and SOD, CAT and GSH-Px activities of all groups

  Markers                            Group 1       Group 2                                                                                                  Group 3                                                                                                   Group 4       Group 5                                                                                                Group 6
  ---------------------------------- ------------- -------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- ------------- ------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------
  TOS (µmol H~2~O~2~ Eq/g protein)   7.01±0.48     10.10±1.68[\*](#tfn7-dddt-12-409){ref-type="table-fn"},[a](#tfn10-dddt-12-409){ref-type="table-fn"}      12.71±3.95[\*\*\*](#tfn9-dddt-12-409){ref-type="table-fn"},[b](#tfn11-dddt-12-409){ref-type="table-fn"}   7.78±1.00     6.39±0.65[\*\*](#tfn8-dddt-12-409){ref-type="table-fn"},[c](#tfn12-dddt-12-409){ref-type="table-fn"}   6.36±0.30[\*\*\*](#tfn9-dddt-12-409){ref-type="table-fn"},[d](#tfn13-dddt-12-409){ref-type="table-fn"}
  TAS (mmol Trolax Eq/g protein)     0.50±0.09     0.45±0.03                                                                                                0.35±0.12[\*](#tfn7-dddt-12-409){ref-type="table-fn"},[b](#tfn11-dddt-12-409){ref-type="table-fn"}        0.52±0.04     0.42±0.07                                                                                              0.37±0.02
  OSI (arbitrary unit)               1.44±0.36     2.22±0.39                                                                                                3.90±1.67[\*\*\*](#tfn9-dddt-12-409){ref-type="table-fn"},[b](#tfn11-dddt-12-409){ref-type="table-fn"}    1.50±0.27     1.54±0.26                                                                                              1.71±0.14[\*\*\*](#tfn9-dddt-12-409){ref-type="table-fn"},[d](#tfn13-dddt-12-409){ref-type="table-fn"}
  MDA (nmol/g protein)               6.29±0.79     8.33±0.86[\*](#tfn7-dddt-12-409){ref-type="table-fn"},[a](#tfn10-dddt-12-409){ref-type="table-fn"}       10.17±1.10[\*\*\*](#tfn9-dddt-12-409){ref-type="table-fn"},[b](#tfn11-dddt-12-409){ref-type="table-fn"}   4.73±1.15     5.88±0.40[\*\*](#tfn8-dddt-12-409){ref-type="table-fn"},[c](#tfn12-dddt-12-409){ref-type="table-fn"}   6.37±1.92[\*\*\*](#tfn9-dddt-12-409){ref-type="table-fn"},[d](#tfn13-dddt-12-409){ref-type="table-fn"}
  SOD (U/g protein)                  41.02±12.93   42.99±9.48                                                                                               35.93±6.61                                                                                                43.49±10.19   45.02±13.35                                                                                            49.63±12.29
  CAT (k/g)                          4.04±0.87     3.04±0.69                                                                                                2.41±0.44[\*\*](#tfn8-dddt-12-409){ref-type="table-fn"},[b](#tfn11-dddt-12-409){ref-type="table-fn"}      4.12±0.97     3.62±0.85                                                                                              3.14±0.80
  GSH-Px (U/g protein)               43.03±7.67    32.25±4.38                                                                                               29.94±5.50[\*](#tfn7-dddt-12-409){ref-type="table-fn"},[b](#tfn11-dddt-12-409){ref-type="table-fn"}       48.79±11.90   44.39±5.77[\*](#tfn7-dddt-12-409){ref-type="table-fn"},[c](#tfn12-dddt-12-409){ref-type="table-fn"}    42.55±7.64[\*](#tfn7-dddt-12-409){ref-type="table-fn"},[d](#tfn13-dddt-12-409){ref-type="table-fn"}
  GSH (nmol/mg protein)              3.14±0.52     2.03±0.30[\*\*\*](#tfn9-dddt-12-409){ref-type="table-fn"},[a](#tfn10-dddt-12-409){ref-type="table-fn"}   1.84±0.15[\*\*\*](#tfn9-dddt-12-409){ref-type="table-fn"},[b](#tfn11-dddt-12-409){ref-type="table-fn"}    3.23±0.54     2.77±0.34[\*](#tfn7-dddt-12-409){ref-type="table-fn"},[c](#tfn12-dddt-12-409){ref-type="table-fn"}     2.58±0.47[\*](#tfn7-dddt-12-409){ref-type="table-fn"},[d](#tfn13-dddt-12-409){ref-type="table-fn"}

**Notes:** Group 1, sham: Group 2, bilateral ovarian torsion; Group 3, bilateral ovarian torsion--detorsion; Group 4, MgSO~4~--sham; Group 5, MgSO~4~--bilateral ovarian torsion; Group 6, bilateral ovarian torsion--MgSO~4~--detorsion. Data are expressed as the mean ± standard deviation.

*p*\<0.05;

*p*\<0.01;

*p*\<0.001.

Group 2 vs Group 1;

Group 3 vs Group 1;

Group 5 vs Group 2;

Group 6 vs Group 3.

**Abbreviations:** TOS, total oxidant status; TAS, total antioxidant status; OSI, Oxidative Stress Index; MDA, malondialdehyde; GSH, glutathione; SOD, superoxide dismutase; CAT, catalase; GSH-Px, glutathione peroxidase; MgSO~4~, magnesium sulfate.
